Andrew Joseph Muir
Chief, Division of Gastroenterology in the Department of Medicine · Duke Department of Medicine
Credentials: ·
History
- Present
Division of Gastroenterology in the Department of Medicine · Duke Department of Medicine
- Present
Duke Department of Medicine
- Present
Duke Clinical Research Institute
Research
Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
Nature · 2009 · 2,916 citations
Telaprevir for previously untreated chronic hepatitis C virus infection
New England Journal of Medicine · 2011 · 1,955 citations
Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection
New England Journal of Medicine · 2014 · 1,431 citations
- JM
51 papers
- MS
27 papers
22 papers
20 papers
20 papers
20 papers
19 papers · 15 as a resident
18 papers · 5 as a fellow
Grants
- 1988–2027
Duke Training Grant in Digestive Diseases and Nutrition
National Institute of Diabetes and Digestive and Kidney Diseases · T32
Contact PI · $2.7M · Duke University
- 2013–2019
RCT of an Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Abuse
National Institute on Alcohol Abuse and Alcoholism · R01
PI · $3.5M · Duke University
- 2011–2012
Support of Yerkes National Primate Research Center
National Center for Research Resources · P51
Project lead · $32.9K · Emory University
- 2008–2011
Integrated Treatment of Persons with Co-Occurring HCV and Alcohol Use/Abuse
National Institute on Alcohol Abuse and Alcoholism · R21
Contact PI · $409.5K · Duke University
Clinical trials
- 2016–2019
Hepatitis C Virus(HCV) Heart and Lung Study
Principal investigator · Completed · Phase 4
Duke University
- 2016–2018
Quality of Life in Patients With Primary Sclerosing Cholangitis
Principal investigator · Completed
Duke University
- 2014–2018
- 2010–2011
Study of SCY-635, Pegasys and Copegus in Hepatitis C
Principal investigator · Completed · Phase 2
Scynexis, Inc.